Jump to main content
Jump to site search

Issue 9, 2018
Previous Article Next Article

Transfection by cationic gemini lipids and surfactants

Author affiliations


Diseases that are linked to defective genes or mutations can in principle be cured by gene therapy, in which damaged or absent genes are either repaired or replaced by new DNA in the nucleus of the cell. Related to this, disorders associated with elevated protein expression levels can be treated by RNA interference via the delivery of siRNA to the cytoplasm of cells. Polynucleotides can be brought into cells by viruses, but this is not without risk for the patient. Alternatively, DNA and RNA can be delivered by transfection, i.e. by non-viral vector systems such as cationic surfactants, which are also referred to as cationic lipids. In this review, recent progress on cationic lipids as transfection vectors will be discussed, with special emphasis on geminis, surfactants with 2 head groups and 2 tails connected by a spacer.

Graphical abstract: Transfection by cationic gemini lipids and surfactants

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 May 2018, accepted on 11 Jul 2018 and first published on 17 Jul 2018

Article type: Review Article
DOI: 10.1039/C8MD00249E
Citation: Med. Chem. Commun., 2018,9, 1404-1425
  •   Request permissions

    Transfection by cationic gemini lipids and surfactants

    M. Damen, A. J. J. Groenen, S. F. M. van Dongen, R. J. M. Nolte, B. J. Scholte and M. C. Feiters, Med. Chem. Commun., 2018, 9, 1404
    DOI: 10.1039/C8MD00249E

Search articles by author